798 results

• Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization

  May 27, 2026

  Michael Adams

  Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.

• Mounjaro NAION Lawsuit Claims Side Effects Led to Permanent Vision Loss

  May 21, 2026

  Irvin Jackson

  A Mounjaro vision loss lawsuit accuses Eli Lilly of failing to properly investigate the drug's side effects and provide proper warnings before marketing it to the public.

• Ozempic and Mounjaro Drug Class Linked to 35% Higher NAION Vision Loss Risk

  May 14, 2026

  Irvin Jackson

  New research provides further evidence that Ozempic and similar drugs can increase the risk of a rare, but often permanent, form of vision loss.

• Ozempic Vision Loss Lawsuit Highlights Devastating Consequences of NAION Diagnosis

  May 4, 2026

  Irvin Jackson

  A Massachusetts man has filed an Ozempic vision loss lawsuit claiming the diabetes drug injections caused a condition that eroded his vision in both eyes.

• Recalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods

  April 30, 2026

  Michael Adams

  Insulet is removing certain Omnipod 5 insulin pump pods from use following a surge in reports of insulin delivery failures that raise risks of diabetic ketoacidosis and other serious complications.

• GLP-1 Dementia, Alzheimer’s Disease Risks Questioned in New Study

  April 27, 2026

  Irvin Jackson

  A new study finds cognitive decline in patients taking GLP-1 medications for longer than 10 years, yet researchers say it may be the result of those patients living longer than their peers.

• Freestyle Libre 2 Lawsuit Alleges Faulty Blood Sugar Readings Resulted in Near-Fatal DKA Event

  April 24, 2026

  Michael Adams

  A Louisiana woman has filed a product liability lawsuit alleging a Freestyle Libre 2 CGM provided false low or normal blood sugar readings, delaying treatment and leading to a near-fatal DKA event.

• Gastrointestinal Problems Are Most Common GLP-1 Side Effects, Study Finds

  April 6, 2026

  Irvin Jackson

  A new study links GLP-1 medications to increased gastrointestinal risks, while also raising broader concerns about other potential complications associated with the diabetes and weight loss drugs.

• Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death

  March 24, 2026

  Michael Adams

  Following reports that some Omnipod 5 insulin pods may malfunction and deliver incorrect insulin doses, attorneys are investigating potential lawsuits involving alleged design defects, inadequate testing, and failure to warn about the risk of these dangerous errors.

• Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA

  March 20, 2026

  Michael Adams

  Omnipod 5 lawsuits are now being investigated following a recall of certain insulin pods over the risk that they may malfunction and deliver incorrect doses.